http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2005217148-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8828412a08c427cf0e753b98d7339754 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-065 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0017 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0023 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-00 |
| filingDate | 2005-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fb785a80670770e4e7ef31eedc6fbce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b230ca12f9198ea92497ad9c6ac8345 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15aa70258cac20b2fd4655a5b2ebde24 |
| publicationDate | 2011-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2005217148-B2 |
| titleOfInvention | A method of providing a purified, virus safe antibody preparation |
| abstract | A method of preparing a purified, virus inactivated and virus safe antibody preparation from a starting solution comprising antibodies and contaminants, the method comprising the steps of: (a) adjusting the pH of the starting solution to about 4.6 to about 4.95 in particular to about 4.8 to about 4.95 to produce an intermediate solution; (b) adding caprylate and/or heptanoate ions to the intermediate solution and maintaining the pH at about 4.6 to about 4.95 in particular pH at about 4.8 to about 4.95, whereby a precipitate is formed and the antibodies are essentially present in the supernatant; (c) incubating the supernatant solution under conditions of caprylate and/or heptanoate ion concentration, time, pH and temperature optionally concentrating and diafiltrating the filtrated solution before pH adjustment; (d) applying the filtered solution with a least one anion exchange resin and optionally with two different anion exchange resins under conditions that allow binding of contaminants to the resin while not allowing significant binding' of the antibodies to the resin, wherein a purified, virus inactivated and virus safe antibody preparation is produced. |
| priorityDate | 2004-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.